Goldman Calls Medicis (MRX) 'One of the Most Likely M&A Targets' in Specialty Pharma Space
Go back to Goldman Calls Medicis (MRX) 'One of the Most Likely M&A Targets' in Specialty Pharma Space| Medicis Pharmaceutical Corp. (NASDAQ: MRX) | Delayed: 65.56 +1.32 (2.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.24 | 52 Week High | $44.00 | |||
| Open | $65.43 | 52 Week Low | $30.30 | |||
| Day High | $65.87 | P/E | 95.01 | |||
| Day Low | $64.03 | EPS | $0.69 | |||
| Volume | 582,467 | |||||
